Saturday | 5 October 2024 | Reg No- 06
বাংলা
   
Saturday | 5 October 2024 | Epaper
BREAKING: ● 3 die in Sherpur flood; 60,000 stranded      ● Ex-president Badruddoza Chowdhury passes away      ● Killing during students' movement: 9 bodies to be exhumed in Sylhet      ● Malaysian prime minister leaves Dhaka for home      ● CA seeks Malaysian support for Bangladesh to be ASEAN dialogue partner      ● Malaysian PM assures of attention to 18,000 Bangladesh workers       ● Bid to kill Khaleda Zia: Sheikh Hasina among 113 sued      

Salman, Verma open new Indian medicinal plant in Bangladesh

Published : Sunday, 26 May, 2024 at 12:00 AM  Count : 322
Private Industry and Investment Adviser of Bangladesh Prime Minister Salman F Rahman and Indian High Commissioner to Bangladesh Pranay Verma on Saturday jointly inaugurated a new plant of Indias leading pharmaceutical company, Sun Pharma, at Meghna Industrial Economic Zone.

Sun Pharma is the worlds fourth largest specialty generic pharmaceutical company with operations in over 100 countries.
This is the companys second investment in Bangladesh with a production capacity of over 1 billion tablets and capsules per year.
Speaking at the ceremony, the High Commissioner highlighted the new investment as part of the growing economic and industrial engagement between Bangladesh and India, and a visible symbol of the recent transformation of their relationship.

He stressed that the plant, which is the first pharmaceutical unit in any Economic Zone of Bangladesh, is not just a testament to Indias continued commitment to promote partnership with Bangladesh, but also reflects the growing interest among Indian businesses to invest in Bangladesh.

High Commissioner Verma noted the strong bilateral cooperation in the health sector, including the close engagement during the COVID-19 pandemic when India supplied vaccines under Vaccine Maitri and Oxygen Express trains to Bangladesh, while Bangladesh gifted critical medicines to India.

Recognizing the significant progress made by Bangladeshs pharmaceutical industry in the last few decades, the High Commissioner underscored the emergence of Bangladesh as a key player in generic drug manufacturing.

He noted that India has been a credible partner in the growth story of Bangladeshs pharmaceutical industry meeting about 30% of the Active Pharmaceutical Ingredients (API) demand of Bangladesh.

With a renewed focus on domestic production backed by a host of government incentives, he said that there are ample opportunities for Indian manufacturers to establish business partnerships with Bangladesh companies in the form of Joint Ventures, joint R&D efforts and technology tie-ups.

The High Commissioner highlighted that new Indian investments into Bangladesh demonstrated by todays event not only strengthens bilateral economic ties but also marks another step towards establishing stronger supply chain and value chain linkages between the two economies, which he said was the way to reinforce the economic ties between the two countries oriented towards the future.    —UNB



LATEST NEWS
MOST READ
Also read
Berger Paints declares 500pc cash dividend 
Illegal items may get in as BD scraps physical inspection of Pak imports
RAKUB sets Tk 4,100cr loan disbursement target in NW zone
Jibon Bima seeks Ministry's help to recover Tk 126.95cr from Padma Bank
BEA rejects ad hoc committee formation
NRBs can get bank loans up to Tk 10 lakh without collaterals 
Ethiopian Airlines offers B1G1 ticket marking Bangladesh debut
BSEC Chairman's resignation demanded amid market instability
Editor : Iqbal Sobhan Chowdhury
Published by the Editor on behalf of the Observer Ltd. from Globe Printers, 24/A, New Eskaton Road, Ramna, Dhaka.
Editorial, News and Commercial Offices : Aziz Bhaban (2nd floor), 93, Motijheel C/A, Dhaka-1000.
Phone: PABX- 41053001-06; Online: 41053014; Advertisement: 41053012.
E-mail: info©dailyobserverbd.com, news©dailyobserverbd.com, advertisement©dailyobserverbd.com, For Online Edition: mailobserverbd©gmail.com
🔝